Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-493' Or cancer = '' Total: 12 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-493 bladder cancer down Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.
hsa-mir-493 gastric cancer up miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells.
hsa-mir-493 gastric cancer down MiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC.
hsa-mir-493 hepatocellular carcinoma down MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2).
hsa-mir-493 hepatocellular carcinoma down MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
hsa-mir-493 malignant melanoma down Downregulation of miR-493 promoted melanoma proliferation by suppressing IRS4 expression.
hsa-mir-493 pancreatic cancer down miR-493 inhibits proliferation and invasion in pancreatic cancer cells and inversely regulated hERG1 expression.
hsa-mir-493 pituitary carcinoma up MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.
hsa-mir-493-3p prostate cancer down Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.
hsa-mir-493-5p hepatocellular carcinoma down miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
hsa-mir-493-5p liver cancer down MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
hsa-mir-493-5p prostate cancer down c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3?/Snail signaling in prostate cancer.